Healthy Volunteer Study Comparing Tablet and Capsule Formulations
NCT04001998
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
On hold to determine chosen formulations
Conditions
Fibrosis
Interventions
DRUG:
BLD-2660
Sponsor
Blade Therapeutics